Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic outcomes of empiric vancomycin in febrile neutropenia of hematologic malignancy patients
TCTR20221029001Unknown
- Sponsor
- N/A
- Start
- Nov 2022
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of vancomycin in febrile neutropenia (FN) and hematopoietic malignancies, sponsored by N/A. Status: unknown.
02
Drugs
vancomycin
03
Conditions
febrile neutropenia (FN)hematopoietic malignancies
Beyond the preview
Go deeper on TCTR20221029001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221029001.